G1 Execution Services, LLC 13D and 13G filings for Nektar Therapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 5:17 pm Sale | 2025-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | G1 Execution Services, LLC | 809,967 4.000% | -425,897 (-34.46%) | Filing |
| 2025-11-13 5:45 pm Purchase | 2025-09-30 | 13G | NEKTAR THERAPEUTICS NKTR | G1 Execution Services, LLC | 1,235,864 6.300% | 1,235,864 (New Position) | Filing |